0001104659-19-048436.txt : 20190903
0001104659-19-048436.hdr.sgml : 20190903
20190903160429
ACCESSION NUMBER: 0001104659-19-048436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190830
FILED AS OF DATE: 20190903
DATE AS OF CHANGE: 20190903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Broom Colin MD
CENTRAL INDEX KEY: 0001289946
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 191072159
MAIL ADDRESS:
STREET 1: 119 FRINGETREE DRIVE
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2019-08-30
0
0001641640
Nabriva Therapeutics plc
NBRV
0001289946
Broom Colin MD
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
1
0
0
0
Ordinary Shares
2019-08-30
4
P
0
10177
2.0309
A
208750
D
The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,177 shares, with the reporting person's sale of 10,177 ordinary shares at a price of $2.07 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $397.93, representing the full amount of the profit realized in connection with the short-swing transaction.
This amount represents the reporting person's total holdings of ordinary shares of the Issuer, including 72,849 ordinary shares formerly held indirectly by the reporting person in a grantor retained annuity trust. The grantor retained annuity trust has been terminated and the ordinary shares have been returned to the direct ownership of the reporting person.
/s/ Robert Crotty, by power of attorney
2019-09-03